Updates – EBPMN

Updates

Updates

October 18th, 2022 - Webinar - WHO Biosimilar Guidelines: A linear progression towards Accessibility?

Data: 13/12/2022

November 28th, 2022 - Webinar - Intelectual property for biological products

Data: 13/12/2022

August 4th, 2022 - Webinar - Speed to market using single use technology in biotherapeutics manufacturing

Data: 13/12/2022

February 24th, 2022 - Webinar - Technology transfer as a basis for access to LMICs in the production of biosimilar products

Data: 06/04/2022

December 3, 2021 - Webinar - Bacteriophages and the encoded lysin enzymes as potential therapeutics

Data: 21/12/2021

September 30th, 2021 - Webinar - Biologicals manufacturing in contract manufacturing facilities

Data: 25/10/2021

August 25th, 2021 - Webinar - Biopharmaceuticals manufacturing under regulatory compliance

Data: 24/09/2021

May 27th, 2021 - Webinar - Biosimilars in Russia - a case of Biocad

Data: 27/05/2021

March 11, 2021 - Webinar - How to create access to biosimilars in Low and Middle-Income Countries?

Data: 11/03/2021

November 17, 2020 - Webinar - Biopharmaceuticals in Brazil

Data: 18/11/2020

October 15, 2020 - Webinar - Human Insulin: Access and Market Considerations in LMICs

Data: 27/10/2020

September 18, 2020 - Webinar - ACT Therapeutics Pillar

Data: 25/09/2020

June 4, 2020 - Webinar – Covid-19 Convalescent Plasma Therapy

June 4th Webinar – Covid-19 Convalescent Plasma Therapy
Data: 04/06/2020

May 7, 2020 - Webinar – Covid-19

Data: 07/05/2020